Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation
The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late‐onset (≥6 months) allograft injury would produce an augmented CXCR3/ligand immune response, leading to increased CLAD. In a retrospective singl...
Saved in:
Published in | American journal of transplantation Vol. 17; no. 5; pp. 1294 - 1303 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Limited
01.05.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late‐onset (≥6 months) allograft injury would produce an augmented CXCR3/ligand immune response, leading to increased CLAD. In a retrospective single‐center study, 1894 transbronchial biopsy samples from 441 lung transplant recipients were reviewed for the presence of acute rejection (AR), lymphocytic bronchiolitis (LB), diffuse alveolar damage (DAD), and organizing pneumonia (OP). The association between the time of onset of each injury pattern and CLAD was assessed by using multivariable Cox models with time‐dependent covariates. Bronchoalveolar lavage (BAL) CXCR3 ligand concentrations were compared between early‐ and late‐onset injury patterns using linear mixed‐effects models. Late‐onset DAD and OP were strongly associated with CLAD: adjusted hazard ratio 2.8 (95% confidence interval 1.5–5.3) and 2.0 (1.1–3.4), respectively. The early‐onset form of these injury patterns did not increase CLAD risk. Late‐onset LB and acute rejection (AR) predicted CLAD in univariable models but lost significance after multivariable adjustment for late DAD and OP. AR was the only early‐onset injury pattern associated with CLAD development. Elevated BAL CXCR3 ligand concentrations during late‐onset allograft injury parallel the increase in CLAD risk and support our hypothesis that late allograft injuries result in a more profound CXCR3/ligand immune response.
The authors demonstrate the importance of time‐of‐onset when considering the association between allograft injury and chronic lung allograft dysfunction (CLAD) and report that late‐onset diffuse alveolar damage and organizing pneumonia markedly increase CLAD risk, whereas the early‐onset form of these injury patterns seems to be less important. |
---|---|
AbstractList | The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late-onset (≥6 months) allograft injury would produce an augmented CXCR3/ligand immune response, leading to increased CLAD. In a retrospective single-center study, 1894 transbronchial biopsy samples from 441 lung transplant recipients were reviewed for the presence of acute rejection (AR), lymphocytic bronchiolitis (LB), diffuse alveolar damage (DAD), and organizing pneumonia (OP). The association between the time of onset of each injury pattern and CLAD was assessed by using multivariable Cox models with time-dependent covariates. Bronchoalveolar lavage (BAL) CXCR3 ligand concentrations were compared between early- and late-onset injury patterns using linear mixed-effects models. Late-onset DAD and OP were strongly associated with CLAD: adjusted hazard ratio 2.8 (95% confidence interval 1.5-5.3) and 2.0 (1.1-3.4), respectively. The early-onset form of these injury patterns did not increase CLAD risk. Late-onset LB and acute rejection (AR) predicted CLAD in univariable models but lost significance after multivariable adjustment for late DAD and OP. AR was the only early-onset injury pattern associated with CLAD development. Elevated BAL CXCR3 ligand concentrations during late-onset allograft injury parallel the increase in CLAD risk and support our hypothesis that late allograft injuries result in a more profound CXCR3/ligand immune response. The authors demonstrate the importance of time-of-onset when considering the association between allograft injury and chronic lung allograft dysfunction (CLAD) and report that late-onset diffuse alveolar damage and organizing pneumonia markedly increase CLAD risk, whereas the early-onset form of these injury patterns seems to be less important. The impact of allograft injury time-of-onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late -onset (≥6 months) allograft injury would produce an augmented CXCR3/ligand immune response, leading to increased CLAD. In a retrospective single-center study, 1894 transbronchial biopsies from 441 lung transplant recipients were reviewed for the presence of acute rejection (AR), lymphocytic bronchiolitis (LB), diffuse alveolar damage (DAD) and organizing pneumonia (OP). The association between the time-of-onset of each injury pattern and CLAD was assessed using multivariable Cox models with time-dependent covariates. BAL CXCR3 ligand concentrations were compared between early and late -onset injury patterns using linear mixed-effects models. Late -onset DAD and OP were strongly associated with CLAD: adjusted HRs 2.8 95%CI 1.5-5.3 and 2.0 95%CI 1.1-3.4, respectively. The early -onset form of these injury patterns did not increase CLAD risk. Late -onset LB and AR predicted CLAD in univariable models, but lost significance after multivariable adjustment for late DAD and OP. AR was the only early -onset injury pattern associated with CLAD development. Elevated BAL CXCR3 ligand concentrations during late -onset allograft injury parallel the increase in CLAD risk and support our hypothesis that late allograft injuries result in a more profound CXCR3/ligand immune response. The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late-onset (≥6 months) allograft injury would produce an augmented CXCR3/ligand immune response, leading to increased CLAD. In a retrospective single-center study, 1894 transbronchial biopsy samples from 441 lung transplant recipients were reviewed for the presence of acute rejection (AR), lymphocytic bronchiolitis (LB), diffuse alveolar damage (DAD), and organizing pneumonia (OP). The association between the time of onset of each injury pattern and CLAD was assessed by using multivariable Cox models with time-dependent covariates. Bronchoalveolar lavage (BAL) CXCR3 ligand concentrations were compared between early- and late-onset injury patterns using linear mixed-effects models. Late-onset DAD and OP were strongly associated with CLAD: adjusted hazard ratio 2.8 (95% confidence interval 1.5-5.3) and 2.0 (1.1-3.4), respectively. The early-onset form of these injury patterns did not increase CLAD risk. Late-onset LB and acute rejection (AR) predicted CLAD in univariable models but lost significance after multivariable adjustment for late DAD and OP. AR was the only early-onset injury pattern associated with CLAD development. Elevated BAL CXCR3 ligand concentrations during late-onset allograft injury parallel the increase in CLAD risk and support our hypothesis that late allograft injuries result in a more profound CXCR3/ligand immune response.The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late-onset (≥6 months) allograft injury would produce an augmented CXCR3/ligand immune response, leading to increased CLAD. In a retrospective single-center study, 1894 transbronchial biopsy samples from 441 lung transplant recipients were reviewed for the presence of acute rejection (AR), lymphocytic bronchiolitis (LB), diffuse alveolar damage (DAD), and organizing pneumonia (OP). The association between the time of onset of each injury pattern and CLAD was assessed by using multivariable Cox models with time-dependent covariates. Bronchoalveolar lavage (BAL) CXCR3 ligand concentrations were compared between early- and late-onset injury patterns using linear mixed-effects models. Late-onset DAD and OP were strongly associated with CLAD: adjusted hazard ratio 2.8 (95% confidence interval 1.5-5.3) and 2.0 (1.1-3.4), respectively. The early-onset form of these injury patterns did not increase CLAD risk. Late-onset LB and acute rejection (AR) predicted CLAD in univariable models but lost significance after multivariable adjustment for late DAD and OP. AR was the only early-onset injury pattern associated with CLAD development. Elevated BAL CXCR3 ligand concentrations during late-onset allograft injury parallel the increase in CLAD risk and support our hypothesis that late allograft injuries result in a more profound CXCR3/ligand immune response. The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late‐onset (≥6 months) allograft injury would produce an augmented CXCR3/ligand immune response, leading to increased CLAD. In a retrospective single‐center study, 1894 transbronchial biopsy samples from 441 lung transplant recipients were reviewed for the presence of acute rejection (AR), lymphocytic bronchiolitis (LB), diffuse alveolar damage (DAD), and organizing pneumonia (OP). The association between the time of onset of each injury pattern and CLAD was assessed by using multivariable Cox models with time‐dependent covariates. Bronchoalveolar lavage (BAL) CXCR3 ligand concentrations were compared between early‐ and late‐onset injury patterns using linear mixed‐effects models. Late‐onset DAD and OP were strongly associated with CLAD: adjusted hazard ratio 2.8 (95% confidence interval 1.5–5.3) and 2.0 (1.1–3.4), respectively. The early‐onset form of these injury patterns did not increase CLAD risk. Late‐onset LB and acute rejection (AR) predicted CLAD in univariable models but lost significance after multivariable adjustment for late DAD and OP. AR was the only early‐onset injury pattern associated with CLAD development. Elevated BAL CXCR3 ligand concentrations during late‐onset allograft injury parallel the increase in CLAD risk and support our hypothesis that late allograft injuries result in a more profound CXCR3/ligand immune response. The authors demonstrate the importance of time‐of‐onset when considering the association between allograft injury and chronic lung allograft dysfunction (CLAD) and report that late‐onset diffuse alveolar damage and organizing pneumonia markedly increase CLAD risk, whereas the early‐onset form of these injury patterns seems to be less important. The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late-onset (≥6 months) allograft injury would produce an augmented CXCR3/ligand immune response, leading to increased CLAD. In a retrospective single-center study, 1894 transbronchial biopsy samples from 441 lung transplant recipients were reviewed for the presence of acute rejection (AR), lymphocytic bronchiolitis (LB), diffuse alveolar damage (DAD), and organizing pneumonia (OP). The association between the time of onset of each injury pattern and CLAD was assessed by using multivariable Cox models with time-dependent covariates. Bronchoalveolar lavage (BAL) CXCR3 ligand concentrations were compared between early- and late-onset injury patterns using linear mixed-effects models. Late-onset DAD and OP were strongly associated with CLAD: adjusted hazard ratio 2.8 (95% confidence interval 1.5-5.3) and 2.0 (1.1-3.4), respectively. The early-onset form of these injury patterns did not increase CLAD risk. Late-onset LB and acute rejection (AR) predicted CLAD in univariable models but lost significance after multivariable adjustment for late DAD and OP. AR was the only early-onset injury pattern associated with CLAD development. Elevated BAL CXCR3 ligand concentrations during late-onset allograft injury parallel the increase in CLAD risk and support our hypothesis that late allograft injuries result in a more profound CXCR3/ligand immune response. |
Author | Shino, M. Y. Ardehali, A. Huynh, R. H. Lynch, J. P. Derhovanessian, A. Gregson, A. L. Sayah, D. M. Belperio, J. A. Saggar, R. Ross, D. J. Weigt, S. S. Elashoff, R. M. Li, N. |
AuthorAffiliation | 2 Department of Biomathematics, University of California at Los Angeles, Los Angeles, CA 90095-1652 4 Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1741 3 Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1688 1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1690 |
AuthorAffiliation_xml | – name: 4 Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1741 – name: 1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1690 – name: 3 Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1688 – name: 2 Department of Biomathematics, University of California at Los Angeles, Los Angeles, CA 90095-1652 |
Author_xml | – sequence: 1 givenname: M. Y. surname: Shino fullname: Shino, M. Y. email: mshino@mednet.ucla.edu organization: David Geffen School of Medicine at UCLA – sequence: 2 givenname: S. S. surname: Weigt fullname: Weigt, S. S. organization: David Geffen School of Medicine at UCLA – sequence: 3 givenname: N. surname: Li fullname: Li, N. organization: University of California at Los Angeles – sequence: 4 givenname: A. surname: Derhovanessian fullname: Derhovanessian, A. organization: David Geffen School of Medicine at UCLA – sequence: 5 givenname: D. M. surname: Sayah fullname: Sayah, D. M. organization: David Geffen School of Medicine at UCLA – sequence: 6 givenname: R. H. surname: Huynh fullname: Huynh, R. H. organization: David Geffen School of Medicine at UCLA – sequence: 7 givenname: R. surname: Saggar fullname: Saggar, R. organization: David Geffen School of Medicine at UCLA – sequence: 8 givenname: A. L. orcidid: 0000-0001-6806-0868 surname: Gregson fullname: Gregson, A. L. organization: David Geffen School of Medicine at UCLA – sequence: 9 givenname: A. surname: Ardehali fullname: Ardehali, A. organization: David Geffen School of Medicine at UCLA – sequence: 10 givenname: D. J. surname: Ross fullname: Ross, D. J. organization: David Geffen School of Medicine at UCLA – sequence: 11 givenname: J. P. surname: Lynch fullname: Lynch, J. P. organization: David Geffen School of Medicine at UCLA – sequence: 12 givenname: R. M. surname: Elashoff fullname: Elashoff, R. M. organization: University of California at Los Angeles – sequence: 13 givenname: J. A. surname: Belperio fullname: Belperio, J. A. organization: David Geffen School of Medicine at UCLA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27676455$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kUtrGzEUhUVJaR7ton-gDHTTLpzoMSNpNgXj9OFiyMZdC0Vzx5bRSFNpJsXQH18544Q0tNpIcL9zdKRzjk588IDQW4IvSV5XejdckhJz_gKdEY7xjJOSnTyeWXWKzlPaYUwElfQVOqWCC15W1Rn6vex6bYYitMXcubCJuh2Kpd-NcV-sbQeHwY1PkAlfDFsoruEOXOg78PeixTYGb02xGv3micP1PrWjN4PNqnk7QJyAddQ-9U77QR9Gr9HLVrsEb477Bfrx5fN68W22uvm6XMxXM1Phms8M1kBpg0vBbwnXtSirBksumgYAM0oq00AtpADRSsErzqWuK8loI7VkZUnYBfo0-fbjbQeNydmjdqqPttNxr4K26u-Jt1u1CXeqYlxiJrLBh6NBDD9HSIPqbDLg8ksgjEmRfE9dU1bzjL5_hu7CGH1-XqZqmrNTQTP17mmixygPxWTgagJMDClFaJWx06flgNYpgtWhepWrV_fVZ8XHZ4oH03-xR_df1sH-_6Caf19Pij_SQ73V |
CitedBy_id | crossref_primary_10_1111_tid_13967 crossref_primary_10_1148_ryct_2021200314 crossref_primary_10_1016_j_transproceed_2024_04_026 crossref_primary_10_1172_jci_insight_158002 crossref_primary_10_1055_s_0041_1729175 crossref_primary_10_1164_rccm_201908_1539OC crossref_primary_10_1183_13993003_02292_2019 crossref_primary_10_1016_j_arbres_2024_06_006 crossref_primary_10_1152_ajplung_00222_2020 crossref_primary_10_1016_j_healun_2018_04_007 crossref_primary_10_1016_j_healun_2023_04_005 crossref_primary_10_1097_TP_0000000000004270 crossref_primary_10_1165_rcmb_2019_0374OC crossref_primary_10_1177_03000605211010734 crossref_primary_10_3389_fmed_2023_1158870 crossref_primary_10_1001_jamanetworkopen_2024_37148 crossref_primary_10_1016_j_trim_2021_101480 crossref_primary_10_1038_s41397_019_0086_0 crossref_primary_10_1172_jci_insight_121782 |
Cites_doi | 10.1016/j.jtcvs.2004.10.035 10.4049/jimmunol.165.1.461 10.1164/rccm.201305-0861OC 10.1111/j.1600-6143.2011.03849.x 10.1097/TP.0b013e3181641df9 10.1097/01.tp.0000181161.60638.fa 10.1111/j.1600-6143.2008.02280.x 10.1016/j.healun.2006.09.002 10.1084/jem.184.3.963 10.1016/S0002-9440(10)64126-0 10.1097/00000478-199305000-00008 10.1164/rccm.200706-951OC 10.1016/j.healun.2013.01.1029 10.1016/S1053-2498(02)00450-3 10.1126/science.1254536 10.1016/j.healun.2007.10.017 10.1016/S1053-2498(99)00047-9 10.1016/j.healun.2009.04.022 10.1016/S1074-7613(00)80091-6 10.1016/j.healun.2011.08.004 10.1111/j.1600-6143.2012.04134.x 10.1038/76907 10.3892/etm.2014.1714 10.1038/nature04753 10.4049/jimmunol.136.7.2348 10.1164/ajrccm.165.2.ats01 10.1016/S1053-2498(02)00398-4 10.1111/ajt.13475 10.1152/ajplung.00330.2003 10.1164/rccm.200310-1359OC 10.1084/jem.187.12.2009 10.1016/S1053-2498(00)00308-9 10.1097/TP.0b013e3181852f02 10.1183/09031936.00157508 10.1164/rccm.201207-1228OC 10.4049/jimmunol.169.2.1037 10.1183/09031936.00064807 10.1164/rccm.200302-165OC 10.1371/journal.pone.0117618 10.1016/j.healun.2011.12.015 10.1016/S1053-2498(01)00405-3 10.1164/rccm.200608-1079OC 10.1097/01.tp.0000209439.27719.ed 10.1097/TP.0b013e31816651de 10.4049/jimmunol.171.9.4844 10.1038/nm0602-567 10.1111/j.1600-6143.2009.02635.x 10.3892/etm.2015.2204 10.1016/S1053-2498(01)00360-6 10.1111/j.1600-6143.2011.03859.x 10.1378/chest.110.5.1150 10.4049/jimmunol.163.4.2267 10.1111/j.1600-6143.2011.03857.x 10.1164/ajrccm.159.3.9607099 10.1111/j.1600-6143.2005.00953.x 10.1016/j.transproceed.2011.12.055 10.1136/thx.2010.155192 10.1016/S0022-5223(97)70144-2 |
ContentType | Journal Article |
Copyright | 2016 The American Society of Transplantation and the American Society of Transplant Surgeons 2016 The American Society of Transplantation and the American Society of Transplant Surgeons. 2017 the American Society of Transplantation and the American Society of Transplant Surgeons |
Copyright_xml | – notice: 2016 The American Society of Transplantation and the American Society of Transplant Surgeons – notice: 2016 The American Society of Transplantation and the American Society of Transplant Surgeons. – notice: 2017 the American Society of Transplantation and the American Society of Transplant Surgeons |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7T5 7U9 H94 K9. 7X8 5PM |
DOI | 10.1111/ajt.14066 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Immunology Abstracts Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Virology and AIDS Abstracts Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | AIDS and Cancer Research Abstracts MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1600-6143 |
EndPage | 1303 |
ExternalDocumentID | PMC5368037 4322060049 27676455 10_1111_ajt_14066 AJT14066 |
Genre | article Clinical Trial Journal Article |
GrantInformation_xml | – fundername: National Institutes of Health/National Center for Advancing Translational Science (NCATS) UCLA CTSI funderid: UL1TR000124; 5U01AI113315‐02; R01 HL112990–01; 5U01AI113315‐02 – fundername: NHLBI NIH HHS grantid: R01 HL112990 – fundername: NIAID NIH HHS grantid: U01 AI113315 – fundername: NCATS NIH HHS grantid: UL1 TR000124 – fundername: NHLBI NIH HHS grantid: K23 HL138256 |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OC 23M 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 6J9 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAFWJ AALRI AAMMB AAONW AASGY AAXRX AAXUO AAYWO AAZKR ABCQN ABCUV ABEML ABJNI ABPPZ ABPVW ABXGK ACAHQ ACCZN ACGFO ACGFS ACMXC ACPOU ACPRK ACSCC ACVFH ACXBN ACXQS ADBBV ADCNI ADEOM ADIZJ ADKYN ADMGS ADOZA ADVLN ADXAS ADZMN AEFGJ AEGXH AEIMD AENEX AEUPX AFBPY AFEBI AFGKR AFJKZ AFPUW AFZJQ AGCQF AGXDD AHMBA AIACR AIAGR AIDQK AIDYY AIGII AITUG AIURR AJAOE AKBMS AKRWK AKYEP ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMRAJ AMYDB APXCP ATUGU AZBYB AZVAB BAFTC BAWUL BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EBS EFKBS EJD EX3 F00 F01 F04 F5P FDB FUBAC G-S G.N GODZA GX1 H.X HF~ HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ TEORI TR2 UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WVDHM WXI XG1 YFH YUY ZZTAW ~IA ~WT AAHHS AAYXX ACCFJ ADZOD AEEZP AEQDE AIWBW AJBDE CITATION 24P AEUQT AFPWT CGR CUY CVF ECM EIF ESX FIJ IPNFZ NPM WRC 7QP 7T5 7U9 H94 K9. 7X8 5PM |
ID | FETCH-LOGICAL-c5096-c0ae22d0476b16a9745d0867ddee03215cde9787e7f8765668a95832d8a834413 |
IEDL.DBID | DR2 |
ISSN | 1600-6135 1600-6143 |
IngestDate | Thu Aug 21 13:56:56 EDT 2025 Fri Jul 11 04:39:05 EDT 2025 Wed Aug 13 07:27:50 EDT 2025 Thu Jan 02 22:52:34 EST 2025 Tue Jul 01 03:25:33 EDT 2025 Thu Apr 24 23:06:20 EDT 2025 Wed Aug 20 07:26:05 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | lung (allograft) function/dysfunction rejection: acute translational research/science clinical research/practice lung transplantation/pulmonology chemokines/chemokine receptors immunobiology rejection: chronic lung failure/injury |
Language | English |
License | 2016 The American Society of Transplantation and the American Society of Transplant Surgeons. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c5096-c0ae22d0476b16a9745d0867ddee03215cde9787e7f8765668a95832d8a834413 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
ORCID | 0000-0001-6806-0868 |
OpenAccessLink | https://escholarship.org/content/qt7rn5f72d/qt7rn5f72d.pdf |
PMID | 27676455 |
PQID | 1892745272 |
PQPubID | 1026366 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5368037 proquest_miscellaneous_1834992396 proquest_journals_1892745272 pubmed_primary_27676455 crossref_citationtrail_10_1111_ajt_14066 crossref_primary_10_1111_ajt_14066 wiley_primary_10_1111_ajt_14066_AJT14066 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2017 |
PublicationDateYYYYMMDD | 2017-05-01 |
PublicationDate_xml | – month: 05 year: 2017 text: May 2017 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Malden |
PublicationTitle | American journal of transplantation |
PublicationTitleAlternate | Am J Transplant |
PublicationYear | 2017 |
Publisher | Elsevier Limited |
Publisher_xml | – name: Elsevier Limited |
References | 1997; 114 2004; 286 1986; 136 1996; 184 2008; 8 1999; 163 2000; 1 2008; 31 2012; 12 1998; 17 2004; 170 1999; 18 2006; 25 2007; 175 2011; 66 1999; 11 2000; 165 2014; 8 2006; 441 2007; 26 2002; 8 2015; 10 2011; 30 2013; 188 2003; 171 2005; 80 2013; 187 2015; 9 2016; 16 1996; 15 2012; 31 2001; 20 2009; 28 2006; 81 2009; 34 1993; 12 1993; 17 2002; 165 2002; 169 2002; 21 2005; 129 2005; 5 2009; 9 1996; 110 2008; 85 2008; 86 2013 2008; 177 1998; 187 1999; 159 2012; 44 2014; 346 2001; 158 El-Gamel (10.1111/ajt.14066_bib30) 1999; 18 Verleden (10.1111/ajt.14066_bib13) 2012; 12 Husain (10.1111/ajt.14066_bib25) 1999; 159 Neurath (10.1111/ajt.14066_bib40) 2002; 8 Belperio (10.1111/ajt.14066_bib35) 2002; 169 Hopkins (10.1111/ajt.14066_bib24) 2004; 170 Agostini (10.1111/ajt.14066_bib54) 2001; 158 Heng (10.1111/ajt.14066_bib31) 1998; 17 Daud (10.1111/ajt.14066_bib51) 2007; 175 Gregson (10.1111/ajt.14066_bib9) 2013; 187 Stewart (10.1111/ajt.14066_bib46) 2007; 26 Sato (10.1111/ajt.14066_bib32) 2012; 31 Chaparro (10.1111/ajt.14066_bib60) 1996; 110 Fisher (10.1111/ajt.14066_bib34) 2002; 21 Glanville (10.1111/ajt.14066_bib21) 2008; 177 Foster (10.1111/ajt.14066_bib56) 2012; 44 Sumpter (10.1111/ajt.14066_bib14) 2004; 286 Veiga-Fernandes (10.1111/ajt.14066_bib59) 2000; 1 Cole (10.1111/ajt.14066_bib37) 1998; 187 Schenkel (10.1111/ajt.14066_bib43) 2014; 346 Crespo (10.1111/ajt.14066_bib62) 2015; 10 Khalifah (10.1111/ajt.14066_bib26) 2005; 5 Billings (10.1111/ajt.14066_bib2) 2002; 21 Heeger (10.1111/ajt.14066_bib61) 1999; 163 Blondeau (10.1111/ajt.14066_bib10) 2008; 31 Yousem (10.1111/ajt.14066_bib29) 1993; 17 Burton (10.1111/ajt.14066_bib23) 2008; 85 Yousem (10.1111/ajt.14066_bib47) 1996; 15 Girgis (10.1111/ajt.14066_bib28) 1996; 15 Weigt (10.1111/ajt.14066_bib6) 2012; 12 Cooper (10.1111/ajt.14066_bib49) 1993; 12 Christie (10.1111/ajt.14066_bib1) 2011; 30 Loetscher (10.1111/ajt.14066_bib38) 1996; 184 10.1111/ajt.14066_bib50 Belperio (10.1111/ajt.14066_bib53) 2000; 165 Botha (10.1111/ajt.14066_bib3) 2008; 85 Zhuang (10.1111/ajt.14066_bib44) 2014; 8 (10.1111/ajt.14066_bib48) 2002; 165 Khalifah (10.1111/ajt.14066_bib4) 2004; 170 Garcia (10.1111/ajt.14066_bib58) 1999; 11 Hachem (10.1111/ajt.14066_bib18) 2005; 80 Wilkes (10.1111/ajt.14066_bib15) 2001; 20 Mosmann (10.1111/ajt.14066_bib41) 1986; 136 Kroshus (10.1111/ajt.14066_bib27) 1997; 114 Burton (10.1111/ajt.14066_bib19) 2008; 86 Weigt (10.1111/ajt.14066_bib8) 2008; 8 Nawrot (10.1111/ajt.14066_bib12) 2011; 66 Belperio (10.1111/ajt.14066_bib36) 2003; 171 Ma (10.1111/ajt.14066_bib42) 2015; 9 Busuttil (10.1111/ajt.14066_bib45) 2009; 34 Flaman (10.1111/ajt.14066_bib57) 2006; 25 Davis (10.1111/ajt.14066_bib17) 2012; 12 Shino (10.1111/ajt.14066_bib33) 2013; 188 Ruttmann (10.1111/ajt.14066_bib5) 2006; 81 Weigt (10.1111/ajt.14066_bib7) 2009; 9 DerHovanessian (10.1111/ajt.14066_bib52) 2016; 16 Neujahr (10.1111/ajt.14066_bib55) 2012; 12 Sharples (10.1111/ajt.14066_bib22) 2002; 21 Bettelli (10.1111/ajt.14066_bib39) 2006; 441 D’Ovidio (10.1111/ajt.14066_bib11) 2005; 129 Burton (10.1111/ajt.14066_bib16) 2009; 28 Estenne (10.1111/ajt.14066_bib20) 2002; 21 |
References_xml | – volume: 85 start-page: 547 year: 2008 end-page: 553 article-title: Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: A retrospective analysis of 2697 transbronchial biopsies publication-title: Transplantation – volume: 21 start-page: 1206 year: 2002 end-page: 1212 article-title: Non‐immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS) publication-title: J Heart Lung Transplant – volume: 12 start-page: 477 year: 2012 end-page: 484 article-title: CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction publication-title: Am J Transplant – volume: 165 start-page: 461 year: 2000 end-page: 472 article-title: The role of the CC chemokine, RANTES, in acute lung allograft rejection publication-title: J Immunol – volume: 34 start-page: 676 year: 2009 end-page: 686 article-title: CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis publication-title: Eur Respir J – volume: 169 start-page: 1037 year: 2002 end-page: 1049 article-title: Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome publication-title: J Immunol – volume: 25 start-page: 1358 year: 2006 end-page: 1362 article-title: Basiliximab versus rabbit anti‐thymocyte globulin for induction therapy in patients after heart transplantation publication-title: J Heart Lung Transplant – volume: 114 start-page: 195 year: 1997 end-page: 202 article-title: Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation publication-title: J Thorac Cardiovasc Surg – volume: 17 start-page: 1255 year: 1998 end-page: 1263 article-title: Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors publication-title: J Heart Lung Transplant – volume: 31 start-page: 354 year: 2012 end-page: 363 article-title: Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation publication-title: J Heart Lung Transplant – volume: 85 start-page: 771 year: 2008 end-page: 774 article-title: Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome publication-title: Transplantation – volume: 17 start-page: 491 year: 1993 end-page: 496 article-title: Lymphocytic bronchitis/bronchiolitis in lung allograft recipients publication-title: Am J Surg Pathol – volume: 8 start-page: 237 year: 2014 end-page: 242 article-title: CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory T cells in a mouse retransplantation model publication-title: Exp Ther Med – volume: 5 start-page: 2022 year: 2005 end-page: 2030 article-title: Minimal acute rejection after lung transplantation: A risk for bronchiolitis obliterans syndrome publication-title: Am J Transplant – volume: 11 start-page: 163 year: 1999 end-page: 171 article-title: Following the development of a CD4 T cell response : From activation to memory formation publication-title: Immunity – volume: 31 start-page: 707 year: 2008 end-page: 713 article-title: Gastro‐oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection publication-title: Eur Respir J – volume: 187 start-page: 518 year: 2013 end-page: 526 article-title: Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation publication-title: Am J Respir Crit Care Med – volume: 81 start-page: 1415 year: 2006 end-page: 1420 article-title: Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation publication-title: Transplantation – volume: 286 start-page: L1129 year: 2004 end-page: L1139 article-title: Role of autoimmunity in organ allograft rejection: A focus on immunity to type V collagen in the pathogenesis of lung transplant rejection publication-title: Am J Physiol Lung Cell Mol Physiol – volume: 9 start-page: 1006 year: 2015 end-page: 1012 article-title: Combination of C‐X‐C motif chemokine 9 and C‐X‐C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model publication-title: Exp Ther Med – volume: 129 start-page: 1144 year: 2005 end-page: 1152 article-title: Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation publication-title: J Thorac Cardiovasc Surg – volume: 12 start-page: 438 year: 2012 end-page: 446 article-title: Cumulative exposure to gamma interferon‐dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant publication-title: Am J Transplant – volume: 8 start-page: 567 year: 2002 end-page: 573 article-title: The role of Th1/Th2 polarization in mucosal immunity publication-title: Nat Med – volume: 30 start-page: 1104 year: 2011 end-page: 1122 article-title: The Registry of the International Society for Heart and Lung Transplantation: Twenty‐eighth adult lung and heart‐lung transplant report–2011 publication-title: J Heart Lung Transplant – volume: 159 start-page: 829 year: 1999 end-page: 833 article-title: Analysis of risk factors for the development of bronchiolitis obliterans syndrome publication-title: Am J Respir Crit Care Med – volume: 441 start-page: 235 year: 2006 end-page: 238 article-title: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells publication-title: Nature – volume: 158 start-page: 1703 year: 2001 end-page: 1711 article-title: Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection publication-title: Am J Pathol – volume: 28 start-page: 888 year: 2009 end-page: 893 article-title: Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post‐transplant baseline FEV1 publication-title: J Heart Lung Transplant – volume: 187 start-page: 2009 year: 1998 end-page: 2021 article-title: Interferon‐inducible T cell alpha chemoattractant (I‐TAC): A novel non‐ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 publication-title: J Exp Med – volume: 184 start-page: 963 year: 1996 end-page: 969 article-title: Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T‐lymphocytes publication-title: J Exp Med – volume: 175 start-page: 507 year: 2007 end-page: 513 article-title: Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome publication-title: Am J Respir Crit Care Med – volume: 20 start-page: 167 year: 2001 article-title: Cell‐mediated immunity to collagen V in lung transplant recipients: Correlation with collagen V release into BAL fluid publication-title: J Heart Lung Transplant – volume: 110 start-page: 1150 year: 1996 end-page: 1154 article-title: Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients publication-title: Chest – volume: 86 start-page: 811 year: 2008 end-page: 819 article-title: Interstitial inflammatory lesions of the pulmonary allograft: A retrospective analysis of 2697 transbronchial biopsies publication-title: Transplantation – volume: 10 start-page: e0117618 year: 2015 article-title: Pre‐transplant donor‐specific T‐cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T‐cell depleting induction therapy publication-title: PLoS ONE – volume: 9 start-page: 1903 year: 2009 end-page: 1911 article-title: Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome publication-title: Am J Transplant – volume: 21 start-page: 559 year: 2002 end-page: 566 article-title: Respiratory viruses and chronic rejection in lung transplant recipients publication-title: J Heart Lung Transplant – volume: 1 start-page: 47 year: 2000 end-page: 53 article-title: Response of naive and memory CD8+ T cells to antigen stimulation publication-title: Nat Immunol – volume: 26 start-page: 1229 year: 2007 end-page: 1242 article-title: Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection publication-title: J Heart Lung Transplant – volume: 15 start-page: 1200 year: 1996 end-page: 1208 article-title: Risk factors for the development of obliterative bronchiolitis after lung transplantation publication-title: J Heart Lung Transplant – volume: 12 start-page: 1831 year: 2012 end-page: 1838 article-title: Lymphocytic bronchiolitis after lung transplantation is associated with daily changes in air pollution publication-title: Am J Transplant – volume: 18 start-page: 828 year: 1999 end-page: 837 article-title: Transforming growth factor beta (TGF‐beta) and obliterative bronchiolitis following pulmonary transplantation publication-title: J Heart Lung Transplant – volume: 8 start-page: 1512 year: 2008 end-page: 1522 article-title: Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post‐lung transplantation publication-title: Am J Transplant – volume: 21 start-page: 297 year: 2002 end-page: 310 article-title: Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria publication-title: J Heart Lung Transplant – volume: 177 start-page: 1033 year: 2008 end-page: 1040 article-title: Severity of lymphocytic bronchiolitis predicts long‐term outcome after lung transplantation publication-title: Am J Respir Crit Care Med – volume: 136 start-page: 2348 year: 1986 end-page: 2357 article-title: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins publication-title: J Immunol – volume: 346 start-page: 98 year: 2014 end-page: 101 article-title: T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses publication-title: Science – volume: 170 start-page: 181 year: 2004 end-page: 187 article-title: Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death publication-title: Am J Respir Crit Care Med – volume: 171 start-page: 4844 year: 2003 end-page: 4852 article-title: Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection publication-title: J Immunol – volume: 170 start-page: 1022 year: 2004 end-page: 1026 article-title: Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis publication-title: Am J Respir Crit Care Med – volume: 44 start-page: 164 year: 2012 end-page: 166 article-title: Induction therapy by anti‐thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes publication-title: Transpl Proc – volume: 165 start-page: 277 year: 2002 end-page: 304 article-title: Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 publication-title: Am J Respir Crit Care Med – volume: 16 start-page: 640 year: 2016 end-page: 649 article-title: The role of TGF‐beta in the association between primary graft dysfunction and bronchiolitis obliterans syndrome publication-title: Am J Transplant – volume: 163 start-page: 2267 year: 1999 end-page: 2275 article-title: Pretransplant frequency of donor‐specific, IFN‐gamma‐producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes publication-title: J Immunol – volume: 12 start-page: 713 year: 1993 end-page: 716 article-title: A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation publication-title: J Heart Lung Transplant – volume: 188 start-page: 1117 year: 2013 end-page: 1125 article-title: CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction publication-title: Am J Respir Crit Care Med – volume: 80 start-page: 1406 year: 2005 end-page: 1413 article-title: The significance of a single episode of minimal acute rejection after lung transplantation publication-title: Transplantation – volume: 15 start-page: 1 issue: 1 Pt 1 year: 1996 end-page: 15 article-title: Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group publication-title: J Heart Lung Transplant – volume: 66 start-page: 748 year: 2011 end-page: 754 article-title: The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation publication-title: Thorax – volume: 12 start-page: 745 year: 2012 end-page: 752 article-title: Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation publication-title: Am J Transplant – volume: 21 start-page: 271 year: 2002 end-page: 281 article-title: Risk factors for bronchiolitis obliterans: A systematic review of recent publications publication-title: J Heart Lung Transplant – year: 2013 – volume: 129 start-page: 1144 year: 2005 ident: 10.1111/ajt.14066_bib11 article-title: Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation publication-title: J Thorac Cardiovasc Surg doi: 10.1016/j.jtcvs.2004.10.035 – volume: 165 start-page: 461 year: 2000 ident: 10.1111/ajt.14066_bib53 article-title: The role of the CC chemokine, RANTES, in acute lung allograft rejection publication-title: J Immunol doi: 10.4049/jimmunol.165.1.461 – volume: 188 start-page: 1117 year: 2013 ident: 10.1111/ajt.14066_bib33 article-title: CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201305-0861OC – volume: 12 start-page: 745 year: 2012 ident: 10.1111/ajt.14066_bib17 article-title: Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2011.03849.x – volume: 85 start-page: 547 year: 2008 ident: 10.1111/ajt.14066_bib23 article-title: Minimal acute cellular rejection remains prevalent up to 2 years after lung transplantation: A retrospective analysis of 2697 transbronchial biopsies publication-title: Transplantation doi: 10.1097/TP.0b013e3181641df9 – volume: 80 start-page: 1406 year: 2005 ident: 10.1111/ajt.14066_bib18 article-title: The significance of a single episode of minimal acute rejection after lung transplantation publication-title: Transplantation doi: 10.1097/01.tp.0000181161.60638.fa – volume: 8 start-page: 1512 year: 2008 ident: 10.1111/ajt.14066_bib8 article-title: Altered levels of CC chemokines during pulmonary CMV predict BOS and mortality post-lung transplantation publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2008.02280.x – volume: 25 start-page: 1358 year: 2006 ident: 10.1111/ajt.14066_bib57 article-title: Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2006.09.002 – volume: 184 start-page: 963 year: 1996 ident: 10.1111/ajt.14066_bib38 article-title: Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes publication-title: J Exp Med doi: 10.1084/jem.184.3.963 – volume: 158 start-page: 1703 year: 2001 ident: 10.1111/ajt.14066_bib54 article-title: Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)64126-0 – volume: 17 start-page: 491 year: 1993 ident: 10.1111/ajt.14066_bib29 article-title: Lymphocytic bronchitis/bronchiolitis in lung allograft recipients publication-title: Am J Surg Pathol doi: 10.1097/00000478-199305000-00008 – volume: 15 start-page: 1200 year: 1996 ident: 10.1111/ajt.14066_bib28 article-title: Risk factors for the development of obliterative bronchiolitis after lung transplantation publication-title: J Heart Lung Transplant – volume: 177 start-page: 1033 year: 2008 ident: 10.1111/ajt.14066_bib21 article-title: Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200706-951OC – volume: 17 start-page: 1255 year: 1998 ident: 10.1111/ajt.14066_bib31 article-title: Bronchiolitis obliterans syndrome: Incidence, natural history, prognosis, and risk factors publication-title: J Heart Lung Transplant – ident: 10.1111/ajt.14066_bib50 doi: 10.1016/j.healun.2013.01.1029 – volume: 21 start-page: 1206 year: 2002 ident: 10.1111/ajt.14066_bib34 article-title: Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS) publication-title: J Heart Lung Transplant doi: 10.1016/S1053-2498(02)00450-3 – volume: 346 start-page: 98 year: 2014 ident: 10.1111/ajt.14066_bib43 article-title: T cell memory. Resident memory CD8 T cells trigger protective innate and adaptive immune responses publication-title: Science doi: 10.1126/science.1254536 – volume: 26 start-page: 1229 year: 2007 ident: 10.1111/ajt.14066_bib46 article-title: Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2007.10.017 – volume: 18 start-page: 828 year: 1999 ident: 10.1111/ajt.14066_bib30 article-title: Transforming growth factor beta (TGF-beta) and obliterative bronchiolitis following pulmonary transplantation publication-title: J Heart Lung Transplant doi: 10.1016/S1053-2498(99)00047-9 – volume: 28 start-page: 888 year: 2009 ident: 10.1111/ajt.14066_bib16 article-title: Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1 publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2009.04.022 – volume: 11 start-page: 163 year: 1999 ident: 10.1111/ajt.14066_bib58 article-title: Following the development of a CD4 T cell response in vivo: From activation to memory formation publication-title: Immunity doi: 10.1016/S1074-7613(00)80091-6 – volume: 30 start-page: 1104 year: 2011 ident: 10.1111/ajt.14066_bib1 article-title: The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth adult lung and heart-lung transplant report–2011 publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2011.08.004 – volume: 12 start-page: 1831 year: 2012 ident: 10.1111/ajt.14066_bib13 article-title: Lymphocytic bronchiolitis after lung transplantation is associated with daily changes in air pollution publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2012.04134.x – volume: 1 start-page: 47 year: 2000 ident: 10.1111/ajt.14066_bib59 article-title: Response of naive and memory CD8+ T cells to antigen stimulation in vivo publication-title: Nat Immunol doi: 10.1038/76907 – volume: 8 start-page: 237 year: 2014 ident: 10.1111/ajt.14066_bib44 article-title: CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory T cells in a mouse retransplantation model publication-title: Exp Ther Med doi: 10.3892/etm.2014.1714 – volume: 441 start-page: 235 year: 2006 ident: 10.1111/ajt.14066_bib39 article-title: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells publication-title: Nature doi: 10.1038/nature04753 – volume: 136 start-page: 2348 year: 1986 ident: 10.1111/ajt.14066_bib41 article-title: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins publication-title: J Immunol doi: 10.4049/jimmunol.136.7.2348 – volume: 165 start-page: 277 year: 2002 ident: 10.1111/ajt.14066_bib48 publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.165.2.ats01 – volume: 21 start-page: 297 year: 2002 ident: 10.1111/ajt.14066_bib20 article-title: Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria publication-title: J Heart Lung Transplant doi: 10.1016/S1053-2498(02)00398-4 – volume: 16 start-page: 640 year: 2016 ident: 10.1111/ajt.14066_bib52 article-title: The role of TGF-beta in the association between primary graft dysfunction and bronchiolitis obliterans syndrome publication-title: Am J Transplant doi: 10.1111/ajt.13475 – volume: 286 start-page: L1129 year: 2004 ident: 10.1111/ajt.14066_bib14 article-title: Role of autoimmunity in organ allograft rejection: A focus on immunity to type V collagen in the pathogenesis of lung transplant rejection publication-title: Am J Physiol Lung Cell Mol Physiol doi: 10.1152/ajplung.00330.2003 – volume: 170 start-page: 181 year: 2004 ident: 10.1111/ajt.14066_bib4 article-title: Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200310-1359OC – volume: 187 start-page: 2009 year: 1998 ident: 10.1111/ajt.14066_bib37 article-title: Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 publication-title: J Exp Med doi: 10.1084/jem.187.12.2009 – volume: 20 start-page: 167 year: 2001 ident: 10.1111/ajt.14066_bib15 article-title: Cell-mediated immunity to collagen V in lung transplant recipients: Correlation with collagen V release into BAL fluid publication-title: J Heart Lung Transplant doi: 10.1016/S1053-2498(00)00308-9 – volume: 86 start-page: 811 year: 2008 ident: 10.1111/ajt.14066_bib19 article-title: Interstitial inflammatory lesions of the pulmonary allograft: A retrospective analysis of 2697 transbronchial biopsies publication-title: Transplantation doi: 10.1097/TP.0b013e3181852f02 – volume: 34 start-page: 676 year: 2009 ident: 10.1111/ajt.14066_bib45 article-title: CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis publication-title: Eur Respir J doi: 10.1183/09031936.00157508 – volume: 187 start-page: 518 year: 2013 ident: 10.1111/ajt.14066_bib9 article-title: Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201207-1228OC – volume: 169 start-page: 1037 year: 2002 ident: 10.1111/ajt.14066_bib35 article-title: Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome publication-title: J Immunol doi: 10.4049/jimmunol.169.2.1037 – volume: 31 start-page: 707 year: 2008 ident: 10.1111/ajt.14066_bib10 article-title: Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection publication-title: Eur Respir J doi: 10.1183/09031936.00064807 – volume: 170 start-page: 1022 year: 2004 ident: 10.1111/ajt.14066_bib24 article-title: Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200302-165OC – volume: 10 start-page: e0117618 year: 2015 ident: 10.1111/ajt.14066_bib62 article-title: Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy publication-title: PLoS ONE doi: 10.1371/journal.pone.0117618 – volume: 31 start-page: 354 year: 2012 ident: 10.1111/ajt.14066_bib32 article-title: Revisiting the pathologic finding of diffuse alveolar damage after lung transplantation publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2011.12.015 – volume: 21 start-page: 559 year: 2002 ident: 10.1111/ajt.14066_bib2 article-title: Respiratory viruses and chronic rejection in lung transplant recipients publication-title: J Heart Lung Transplant doi: 10.1016/S1053-2498(01)00405-3 – volume: 175 start-page: 507 year: 2007 ident: 10.1111/ajt.14066_bib51 article-title: Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.200608-1079OC – volume: 81 start-page: 1415 year: 2006 ident: 10.1111/ajt.14066_bib5 article-title: Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation publication-title: Transplantation doi: 10.1097/01.tp.0000209439.27719.ed – volume: 85 start-page: 771 year: 2008 ident: 10.1111/ajt.14066_bib3 article-title: Pseudomonas aeruginosa colonization of the allograft after lung transplantation and the risk of bronchiolitis obliterans syndrome publication-title: Transplantation doi: 10.1097/TP.0b013e31816651de – volume: 12 start-page: 713 year: 1993 ident: 10.1111/ajt.14066_bib49 article-title: A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation publication-title: J Heart Lung Transplant – volume: 171 start-page: 4844 year: 2003 ident: 10.1111/ajt.14066_bib36 article-title: Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection publication-title: J Immunol doi: 10.4049/jimmunol.171.9.4844 – volume: 8 start-page: 567 year: 2002 ident: 10.1111/ajt.14066_bib40 article-title: The role of Th1/Th2 polarization in mucosal immunity publication-title: Nat Med doi: 10.1038/nm0602-567 – volume: 9 start-page: 1903 year: 2009 ident: 10.1111/ajt.14066_bib7 article-title: Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2009.02635.x – volume: 9 start-page: 1006 year: 2015 ident: 10.1111/ajt.14066_bib42 article-title: Combination of C-X-C motif chemokine 9 and C-X-C motif chemokine 10 antibodies with FTY720 prolongs the survival of cardiac retransplantation allografts in a mouse model publication-title: Exp Ther Med doi: 10.3892/etm.2015.2204 – volume: 21 start-page: 271 year: 2002 ident: 10.1111/ajt.14066_bib22 article-title: Risk factors for bronchiolitis obliterans: A systematic review of recent publications publication-title: J Heart Lung Transplant doi: 10.1016/S1053-2498(01)00360-6 – volume: 12 start-page: 477 year: 2012 ident: 10.1111/ajt.14066_bib6 article-title: CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2011.03859.x – volume: 110 start-page: 1150 year: 1996 ident: 10.1111/ajt.14066_bib60 article-title: Bronchiolitis obliterans organizing pneumonia (BOOP) in lung transplant recipients publication-title: Chest doi: 10.1378/chest.110.5.1150 – volume: 163 start-page: 2267 year: 1999 ident: 10.1111/ajt.14066_bib61 article-title: Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes publication-title: J Immunol doi: 10.4049/jimmunol.163.4.2267 – volume: 12 start-page: 438 year: 2012 ident: 10.1111/ajt.14066_bib55 article-title: Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2011.03857.x – volume: 159 start-page: 829 year: 1999 ident: 10.1111/ajt.14066_bib25 article-title: Analysis of risk factors for the development of bronchiolitis obliterans syndrome publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.159.3.9607099 – volume: 5 start-page: 2022 year: 2005 ident: 10.1111/ajt.14066_bib26 article-title: Minimal acute rejection after lung transplantation: A risk for bronchiolitis obliterans syndrome publication-title: Am J Transplant doi: 10.1111/j.1600-6143.2005.00953.x – volume: 44 start-page: 164 year: 2012 ident: 10.1111/ajt.14066_bib56 article-title: Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes publication-title: Transpl Proc doi: 10.1016/j.transproceed.2011.12.055 – volume: 66 start-page: 748 year: 2011 ident: 10.1111/ajt.14066_bib12 article-title: The impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation publication-title: Thorax doi: 10.1136/thx.2010.155192 – volume: 15 start-page: 1 issue: 1 Pt 1 year: 1996 ident: 10.1111/ajt.14066_bib47 article-title: Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group publication-title: J Heart Lung Transplant – volume: 114 start-page: 195 year: 1997 ident: 10.1111/ajt.14066_bib27 article-title: Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation publication-title: J Thorac Cardiovasc Surg doi: 10.1016/S0022-5223(97)70144-2 |
SSID | ssj0017282 |
Score | 2.3274653 |
Snippet | The impact of allograft injury time of onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of... The impact of allograft injury time-of-onset on the risk of chronic lung allograft dysfunction (CLAD) remains unknown. We hypothesized that episodes of late... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1294 |
SubjectTerms | Acute Lung Injury - diagnosis Acute Lung Injury - etiology Bronchoalveolar Lavage Fluid - chemistry chemokines/chemokine receptors clinical research/practice Female Follow-Up Studies Graft Rejection - diagnosis Graft Rejection - etiology Graft Survival Health risk assessment Humans immunobiology Ligands lung (allograft) function/dysfunction lung failure/injury Lung Transplantation - adverse effects lung transplantation/pulmonology Male Middle Aged Pneumonia Prognosis Pulmonary Alveoli - pathology rejection: acute rejection: chronic Retrospective Studies translational research/science Transplantation, Homologous Transplants & implants |
Title | Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fajt.14066 https://www.ncbi.nlm.nih.gov/pubmed/27676455 https://www.proquest.com/docview/1892745272 https://www.proquest.com/docview/1834992396 https://pubmed.ncbi.nlm.nih.gov/PMC5368037 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8NAFB6KJy8uuFWrjOLBS6TJZDIJnopaqriAWPAghJlkgtYyFZseFH-8700WWqsg3gLzss7bvsmb7xFy6LIMVUU4XCkAKCzRjlQSJkQDckuYn3CF65DXN0Gv718-8IcGOan2whT8EPWCG1qG9ddo4FKNp4xcDnIwc4iY4H-xVgsToruaOgrbLtk_nRDQAR4xXrIKYRVPfeZsLJpLMOfrJKfzVxuAusvksXr0ou7k5XiSq-Pk4xur4z_fbYUslYkp7RSatEoa2qyRzwu7iZKOMtoZWnbrLKcXZgATQXHzCA7cmrEGCUMhlaRTNUg4VlLv0itwKVNXOHsfYzxFnaAdbFJeCBRE60NZ7IYy66TfPb8_7TllvwYnQRIZJ2lL7Xlp2xeBcgMJSIWngJgEeFDdZpBbJKkG0Cq0yMAHQx4ZyoiDR0lDid0-XLZBFszI6C1C3TRgvpdGivu-z8NIuhmoTRgwCf4IMGuTHFUzFyclmTn21BjGFaiBTxjbT9gkB7Xoa8Hg8ZNQq5r-uDTiceyGEWB27gmvSfbrYTA__KcijR5NUIYBZvRYBJfYLLSlvosnAhH4nDeJmNGjWgCpvWdHzPOTpfjmLAjbTMBrWjX5_cHjzuW9Pdj-u-gOWfQwObFlmy2ykL9N9C6kVrnaszb0BY1wIDM |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9tAEB5RONBLKYKWlBQWxKEXo9jr9doSl6gpSmgACQWJS2Wt7bWARhtEnEMRP56Z9UMJDwn1ZmnHz53Xt579BuDA5TmpinREkiBA4al2VKJwQjQit5T7qUhoHfL0LOhf-idX4moJjuq9MCU_RLPgRpZh_TUZOC1Iz1m5ui3QzjFkfoAV6uhNzPm9i4Y8ihov2X-dGNIRIHFR8QpRHU9z6mI0epFivqyUnM9gbQg6XoM_9cOXlSd_D2dFcpg-PON1_N-3-wyfqtyUdUtlWoclbTbgcWD3UbJJzrpjS3CdF2xgbnEuGO0foYFzM9UoYRhmk2yuDInGKvZdNkSvMneF3r8phVRSC9alPuWlQMm1PlblhiizCZfHv0Y_-07VssFJiUfGSTtKe17W8WWQuIFCsCIyBE0SnajucEwv0kwjbpVa5uiGMZUMVSTQqWShooYfLv8Cy2Zi9BYwNwu472VRInzfF2Gk3Bw1Jwy4QpeEsLUFP-qpi9OKz5zaaozjGtfgJ4ztJ2zBfiN6V5J4vCbUruc_rux4GrthhLBdeNJrwV4zjBZIv1WU0ZMZyXCEjR6P8BJfS3Vp7uLJQAa-EC2QC4rUCBC79-KIubm2LN-CB2GHS3xNqydvP3jcPRnZg2_vF92F1f7odBgPB2e_t-GjR7mKreJsw3JxP9PfMdMqkh1rUE91tSRP |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD7UCuKLrXhbbXUUH3xJSTK3hD4t3S7dWqtIC30QwiSZYNtltrjZh5b--J4zubBrFcS3wJxc59y-yZnvAHyMeEWqogOZ5whQeGEDkxucEIvIreCikDmtQ345Vgen4vBMnq3BbrcXpuGH6BfcyDK8vyYDvyqrJSM3FzWaOUbMB_BQqDClvg2j7z13FPVd8r86MaIjPuKypRWiMp7-1NVgdC_DvF8ouZzA-gg03oAf3bM3hSeXO4s63ylufqN1_M-X24QnbWbKho0qPYU1657B7cTvomSzig2nnt66qtnEXeBMMNo9QgNf3dyihGOYS7KlIiQaa7l32RH6lKUrjK7nFFBJKdiQupQ3Ag3T-tQ026Hcczgd75_sHQRtw4agIBaZoAiNjeMyFFrlkTIIVWSJkEmjC7Uhx-SiKC2iVm11hU4YE8nEpBJdSpkYavcR8Rew7mbOvgIWlYqLuExzKYSQSWqiCvUmUdygQ0LQOoBP3cxlRctmTk01plmHavATZv4TDuBDL3rVUHj8SWirm_6steJ5FiUpgnYZ63gA7_thtD_6qWKcnS1IhiNojHmKl3jZaEt_l1grrYSUA9AretQLELf36og7_-k5viVXScg1vqZXk78_eDY8PPEHr_9d9B08-jYaZ0eT489v4HFMiYov4dyC9frXwm5jmlXnb7053QHzfiL- |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+Allograft+Injury+Time+of+Onset+on+the+Development+of+Chronic+Lung+Allograft+Dysfunction+After+Lung+Transplantation&rft.jtitle=American+journal+of+transplantation&rft.au=Shino%2C+M.Y.&rft.au=Weigt%2C+S.S.&rft.au=Li%2C+N.&rft.au=Derhovanessian%2C+A.&rft.date=2017-05-01&rft.issn=1600-6135&rft.volume=17&rft.issue=5&rft.spage=1294&rft.epage=1303&rft_id=info:doi/10.1111%2Fajt.14066&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_ajt_14066 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1600-6135&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1600-6135&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1600-6135&client=summon |